Effects of continuous intravenous infusion with propofol on intestinal metabolites in rats

Li,Jiaying; Zhang,Zhongjie; Liu,Hongyu; Qu,Xutong; Yin,Xueqing; Chen,Lu; Guo,Nana; Wang,Changsong; Zhang,Zhaodi

doi:10.3892/br.2023.1713

Effects of continuous intravenous infusion with propofol on intestinal metabolites in rats

Authors:
- Jiaying Li
- Zhongjie Zhang
- Hongyu Liu
- Xutong Qu
- Xueqing Yin
- Lu Chen
- Nana Guo
- Changsong Wang
- Zhaodi Zhang
View Affiliations

Affiliations: Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China, Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China
Published online on: December 20, 2023 https://doi.org/10.3892/br.2023.1713
Article Number: 25
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Microbial metabolites play an important role in regulating intestinal homeostasis and immune responses. Propofol is a common anesthetic in clinic, but it is not clear whether it affects intestinal metabolites in rats. Tail vein puncture was performed after adaptive feeding for 1 month in eight 2‑month‑old rats and they were given continuous intravenous infusion of propofol for 3 h. The feces of rats were divided into different groups based on time periods, with before and after anesthesia with propofol on days 1, 3 and 7 labeled as groups P, A1, A3 and A7, respectively. The effect of continuous intravenous infusion with propofol on rat fecal metabolites was determined using the non‑targeted metabolomics technique gas chromatography coupled with a time‑of‑flight mass spectrometer analysis. The types and contents of metabolites in rat feces were changed after continuous intravenous infusion with propofol, but the changes were not statistically significant. The contents of the metabolites 3‑hydroxyphenylacetic acid and palmitic acid increased from day 3 to 7, and it was shown that the two metabolites were positively correlated at a statistically significant level. Linoleic acid decreased to its lowest level on day 3, and it returned to pre‑anesthesia level on day 7. At the same time, linoleic acid metabolism was a metabolic pathway that was co‑enriched 7 days after infusion with propofol. Spearman correlation analysis showed that there was significant correlation between some differential metabolites and differential microorganisms. It was observed that zymosterol 1, cytosin and elaidic acid were negatively correlated with Alloprevotella in the A3 vs. P group. In the A7 vs. P group, cortexolone 3 and coprostan‑3‑one were positively correlated with Faecalibacterium, whilst aconitic acid was negatively correlated with it. In conclusion, the present study revealed statistically insignificant effects of continuous intravenous propofol on the intestinal metabolites in rats.

View Figures

View References

1	Budic I, Jevtovic Stoimenov T, Pavlovic D, Marjanovic V, Djordjevic I, Stevic M and Simic D: Clinical importance of potential genetic determinants affecting propofol pharmacokinetics and pharmacodynamics. Front Med (Lausanne). 9(809393)2022.PubMed/NCBI View Article : Google Scholar
2	Koriyama H, Duff JP, Guerra GG and Chan AW: Sedation Withdrawal and Analgesia Team. Is propofol a friend or a foe of the pediatric intensivist? Description of propofol use in a PICU*. Pediatr Crit Care Med. 15:e66–e71. 2014.PubMed/NCBI View Article : Google Scholar
3	Dinis-Oliveira RJ: Metabolic profiles of propofol and fospropofol: Clinical and forensic interpretative aspects. Biomed Res Int. 2018(6852857)2018.PubMed/NCBI View Article : Google Scholar
4	Asghar MU, Cheema HA, Tanveer K and Leinwand J: Propofol infusion and acute pancreatitis: A review. Am J Ther. 27:e371–e374. 2020.PubMed/NCBI View Article : Google Scholar
5	Walsh CT: Propofol: Milk of Amnesia. Cell. 175:10–13. 2018.PubMed/NCBI View Article : Google Scholar
6	Sanada S, Suzuki T, Nagata A, Hashidume T, Yoshikawa Y and Miyoshi N: Intestinal microbial metabolite stercobilin involvement in the chronic inflammation of ob/ob mice. Sci Rep. 10(6479)2020.PubMed/NCBI View Article : Google Scholar
7	Wu X, Wu Y, He L, Wu L, Wang X and Liu Z: Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer. J Cancer. 9:2510–2517. 2018.PubMed/NCBI View Article : Google Scholar
8	Xing PY, Pettersson S and Kundu P: Microbial metabolites and intestinal stem cells tune intestinal homeostasis. Proteomics. 20(e1800419)2020.PubMed/NCBI View Article : Google Scholar
9	Lin D, Hu B, Li P, Zhao Y, Xu Y and Wu D: Roles of the intestinal microbiota and microbial metabolites in acute GVHD. Exp Hematol Oncol. 10(49)2021.PubMed/NCBI View Article : Google Scholar
10	Guo N, Zhang Z, Han C, Chen L, Zheng X, Yu K, Zhang Z and Wang C: Effects of continuous intravenous infusion with propofol on intestinal flora in rats. Biomed Pharmacother. 134(111080)2021.PubMed/NCBI View Article : Google Scholar
11	Shirasaka T, Yonaha T, Onizuka S and Tsuneyoshi I: Effects of orexin-A on propofol anesthesia in rats. J Anesth. 25:65–71. 2011.PubMed/NCBI View Article : Google Scholar
12	Wang Y, Yu T, Yuan C, Yuan J, Luo Z, Pan Y, Zhang Y, Zhang Y and Yu B: Effects of propofol on the dopamine, metabolites and GABAA receptors in media prefrontal cortex in freely moving rats. Am J Transl Res. 8:2301–2308. 2016.PubMed/NCBI
13	Liu H, Yin X, Li J, Cao Y, Wang Y, Mu W, Zhuo Z, Chen L, Zhang Z, Qu X, et al: Preoperative intestinal microbiome and metabolome in elderly patients with delayed neurocognitive recovery. Anaesth Crit Care Pain Med. 41(101140)2022.PubMed/NCBI View Article : Google Scholar
14	Sahinovic MM, Struys MMRF and Absalom AR: Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 57:1539–1558. 2018.PubMed/NCBI View Article : Google Scholar
15	Kam PC and Cardone D: Propofol infusion syndrome. Anaesthesia. 62:690–701. 2007.PubMed/NCBI View Article : Google Scholar
16	Xu D, Yang W and Zhao G: Effect of propofol and inhalation anesthesia on postoperative cognitive dysfunction in the elderly: A meta-analysis. Nan Fang Yi Ke Da Xue Xue Bao. 32:1623–1627. 2012.PubMed/NCBI(In Chinese).
17	Nummela AJ, Laaksonen LT, Laitio TT, Kallionpaa RE, Langsjo JW, Scheinin JM, Vahlberg TJ, Koskela HT, Aittomaki V, Valli KJ, et al: Effects of dexmedetomidine, propofol, sevoflurane and S-ketamine on the human metabolome: A randomised trial using nuclear magnetic resonance spectroscopy. Eur J Anaesthesiol. 39:521–532. 2022.PubMed/NCBI View Article : Google Scholar
18	Xiong X, Liu D, Wang Y, Zeng T and Peng Y: Urinary 3-(3-Hydroxyphenyl)-3-hydroxypropionic Acid, 3-Hydroxyphenylacetic Acid, and 3-Hydroxyhippuric acid are elevated in children with autism spectrum disorders. Biomed Res Int. 2016(9485412)2016.PubMed/NCBI View Article : Google Scholar
19	Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen ML, Bolte E, McTeague M, Sandler R, Wexler H, Marlowe EM, et al: Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis. 35 (Suppl 1):S6–S16. 2002.PubMed/NCBI View Article : Google Scholar
20	Carta G, Murru E, Banni S and Manca C: Palmitic Acid: Physiological role, metabolism and nutritional implications. Front Physiol. 8(902)2017.PubMed/NCBI View Article : Google Scholar
21	Nicholas DA, Zhang K, Hung C, Glasgow S, Aruni AW, Unternaehrer J, Payne KJ, Langridge WHR and De Leon M: Palmitic acid is a toll-like receptor 4 ligand that induces human dendritic cell secretion of IL-1beta. PLoS One. 12(e0176793)2017.PubMed/NCBI View Article : Google Scholar
22	Tran TT, Postal BG, Demignot S, Ribeiro A, Osinski C, Pais de Barros JP, Blachnio-Zabielska A, Leturque A, Rousset M, Ferre P, et al: Short term palmitate supply impairs intestinal insulin signaling via ceramide production. J Biol Chem. 291:16328–16338. 2016.PubMed/NCBI View Article : Google Scholar
23	Chen J, Lv YN, Li XB, Xiong JJ, Liang HT, Xie L, Wan CY, Chen YQ, Wang HS, Liu P and Zheng HQ: Urinary metabolite signatures for predicting elderly stroke survivors with depression. Neuropsychiatr Dis Treat. 17:925–933. 2021.PubMed/NCBI View Article : Google Scholar
24	Ouyang Y, Qiu G, Zhao X, Su B, Feng D, Lv W, Xuan Q, Wang L, Yu D, Wang Q, et al: Metabolome-Genome-Wide association study (mGWAS) reveals novel metabolites associated with future type 2 diabetes risk and susceptibility loci in a case-control study in a Chinese prospective cohort. Glob Chall. 5(2000088)2021.PubMed/NCBI View Article : Google Scholar
25	Ou Y, Chen S, Ren F, Zhang M, Ge S, Guo H, Zhang H and Zhao L: Lactobacillus casei strain shirota alleviates constipation in adults by increasing the pipecolinic acid level in the Gut. Front Microbiol. 10(324)2019.PubMed/NCBI View Article : Google Scholar
26	Takiguchi A, Yoshioka I, Oda Y, Ishii Y and Kirimura K: Constitutive production of aconitate isomerase by Pseudomonas sp. WU-0701 in relation to trans-aconitic acid assimilation. J Biosci Bioeng. 131:47–52. 2021.PubMed/NCBI View Article : Google Scholar
27	Bruni GO and Klasson KT: Aconitic acid recovery from renewable feedstock and review of chemical and biological applications. Foods. 11(573)2022.PubMed/NCBI View Article : Google Scholar
28	Kwan B, Fuhrer T, Zhang J, Darshi M, Van Espen B, Montemayor D, de Boer IH, Dobre M, Hsu CY, Kelly TN, et al: Metabolomic markers of kidney function decline in patients with diabetes: Evidence from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 76:511–520. 2020.PubMed/NCBI View Article : Google Scholar
29	Chen L, Wang S, Zhang Y, Li Y, Zhang X, Ma J, Zou X, Yao T, Li S, Chen J, et al: Multi-omics reveals specific host metabolism-microbiome associations in intracerebral hemorrhage. Front Cell Infect Microbiol. 12(999627)2022.PubMed/NCBI View Article : Google Scholar
30	Luo S, Zhao Y, Zhu S, Liu L, Cheng K, Ye B, Han Y, Fan J and Xia M: Flavonifractor plautii protects against elevated arterial stiffness. Circ Res. 132:167–181. 2023.PubMed/NCBI View Article : Google Scholar
31	Whelan J and Fritsche K: Linoleic acid. Adv Nutr. 4:311–312. 2013.PubMed/NCBI View Article : Google Scholar
32	Choque B, Catheline D, Rioux V and Legrand P: Linoleic acid: Between doubts and certainties. Biochimie. 96:14–21. 2014.PubMed/NCBI View Article : Google Scholar
33	Fritsche KL: Too much linoleic acid promotes inflammation-doesn't it? Prostaglandins Leukot Essent Fatty Acids. 79:173–175. 2008.PubMed/NCBI View Article : Google Scholar
34	Miyamoto J, Mizukure T, Park SB, Kishino S, Kimura I, Hirano K, Bergamo P, Rossi M, Suzuki T, Arita M, et al: A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR40-MEK-ERK pathway. J Biol Chem. 290:2902–2918. 2015.PubMed/NCBI View Article : Google Scholar
35	Khan AA, Alam M, Tufail S, Mustafa J and Owais M: Synthesis and characterization of novel PUFA esters exhibiting potential anticancer activities: An in vitro study. Eur J Med Chem. 46:4878–4886. 2011.PubMed/NCBI View Article : Google Scholar
36	Han C, Zhang Z, Guo N, Li X, Yang M, Peng Y, Ma X, Yu K and Wang C: Effects of sevoflurane inhalation anesthesia on the intestinal microbiome in mice. Front Cell Infect Microbiol. 11(633527)2021.PubMed/NCBI View Article : Google Scholar
37	Tripathi A, Melnik AV, Xue J, Poulsen O, Meehan MJ, Humphrey G, Jiang L, Ackermann G, McDonald D, Zhou D, et al: Intermittent hypoxia and hypercapnia, a hallmark of obstructive sleep apnea, alters the gut microbiome and metabolome. mSystems. 3:e00020–18. 2018.PubMed/NCBI View Article : Google Scholar
38	Pettersen VK, Antunes LCM, Dufour A and Arrieta MC: Inferring early-life host and microbiome functions by mass spectrometry-based metaproteomics and metabolomics. Comput Struct Biotechnol J. 20:274–286. 2022.PubMed/NCBI View Article : Google Scholar